Preventive and Protective Properties of Zingiber officinale (Ginger) in Diabetes Mellitus, Diabetic Complications, and Associated Lipid and Other Metabolic Disorders: A Brief Review

被引：120

作者：

Li, Yiming ^{[1
]}

Tran, Van H. ^{[1
]}

Duke, Colin C. ^{[1
]}

Roufogalis, Basil D. ^{[1
]}

机构：

[1] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia

来源：

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE | 2012年 / 2012卷

基金：

澳大利亚研究理事会;

关键词：

ETHANOLIC EXTRACT; DIETARY GINGER; GLUCOSE-UPTAKE; STREPTOZOTOCIN; SAFETY; CHOLESTEROL; PLASMA; PHARMACOKINETICS; EFFICACY; ENZYMES;

D O I：

10.1155/2012/516870

中图分类号：

R [医药、卫生];

学科分类号：

10 ;

摘要：

Zingiber officinale (ginger) has been used as herbal medicine to treat various ailments worldwide since antiquity. Recent evidence revealed the potential of ginger for treatment of diabetes mellitus. Data from in vitro, in vivo, and clinical trials has demonstrated the antihyperglycaemic effect of ginger. The mechanisms underlying these actions are associated with insulin release and action, and improved carbohydrate and lipid metabolism. The most active ingredients in ginger are the pungent principles, gingerols, and shogaol. Ginger has shown prominent protective effects on diabetic liver, kidney, eye, and neural system complications. The pharmacokinetics, bioavailability, and the safety issues of ginger are also discussed in this update.

引用

页数：10

共 86 条

[1] Mode of action of gingerols and shogaols on 5-HT3 receptors:: Binding studies, cation uptake by the receptor channel and contraction of isolated guinea-pig ileum [J].

Abdel-Aziz, H ;

Windeck, T ;

Ploch, M ;

Verspohl, EJ .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 530 (1-2) :136-143

[2] Beneficial effects of ginger (Zingiber officinale) on carbohydrate metabolism in streptozotocin-induced diabetic rats [J].

Abdulrazaq, Nafiu Bidemi ;

Cho, Maung Maung ;

Win, Ni Ni ;

Zaman, Rahela ;

Rahman, Mohammad Tariqur .

BRITISH JOURNAL OF NUTRITION, 2012, 108 (07) :1194-1201

[3] Anti-diabetic activity of Zingiber officinale in streptozotocin-induced type I diabetic rats [J].

Akhani, SP ;

Vishwakarma, SL ;

Goyal, RK .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 2004, 56 (01) :101-105

[4] Anti-diabetic and hypolipidaemic properties of ginger (Zingiber officinale) in streptozotocin-induced diabetic rats [J].

Al-Amin, Zainab M. ;

Thomson, Martha ;

Al-Qattan, Khaled K. ;

Peltonen-Shalaby, Riitta ;

Ali, Muslim .

BRITISH JOURNAL OF NUTRITION, 2006, 96 (04) :660-666

[5]

Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO

[6]

2-S

[7] Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): A review of recent research [J].

Ali, Badreldin H. ;

Blunden, Gerald ;

Tanira, Musbah O. ;

Nemmar, Abderrahim .

FOOD AND CHEMICAL TOXICOLOGY, 2008, 46 (02) :409-420

[8]

Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc19-S002, 10.2337/dc12-S064, 10.2337/dc23-S002, 10.2337/dc09-S062, 10.2337/dc18-S002]

[9]

Andallu B., 2003, Plant Foods Hum. Nutr, V58, P1, DOI [DOI 10.1023/B:QUAL.0000040352.23559.04, 10.1023/B:QUAL.0000040352.23559.04]

[10]

[Anonymous], 2008, Clin. Nutr. ESPEN

← 1 2 3 4 5 6 7 8 9 →